Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. It offers Management Studio that enables healthcare delivery organizations to own, archive, and communicate imaging data from across the enterprise and connect that data with the electronic medical record. The company's Management Studio comprises enterprise imaging platform, vendor neutral archive, communication workflow engine, routing engine, fetching engine, and migration engine products. It also provides Diagnostic Studio that drives specialty workflows. The company's Diagnostic Studio solutions include PACS solution, Universal Worklist, and QC module. In addition, the company offers Clinical Studio, which provides access to view, navigate, review, and share patient medical data over the Web and across the enterprise. Its Clinical Studio solutions consist of clinical portal, clinical viewer, image sharing, and procedure import/export products. Further, the company provides customer training, software installation, and maintenance and support services; and archive migration services. Mach7 Technologies Limited was founded in 2007 and is based in South Burlington, Vermont.
Industry, Sector and Symbol
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CIKN/A
Phone802-861-7745
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$8.31 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Mach7 Technologies (ASX:M7T) Frequently Asked Questions
What is Mach7 Technologies' stock symbol?
Mach7 Technologies trades on the ASX under the ticker symbol "M7T."
Has Mach7 Technologies been receiving favorable news coverage?
News headlines about M7T stock have trended negative on Sunday, InfoTrie reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Mach7 Technologies earned a news impact score of -2.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Mach7 Technologies.
Who are some of Mach7 Technologies' key competitors?
Some companies that are related to Mach7 Technologies include Sensyne Health (SENS), Alcidion Group (ALC), Kneat.com (KSI), Medadvisor (MDR), Induction Healthcare Group (INHC), Reliq Health Technologies (RHT), Vitalhub (VHI), CogState (CGS), 1ST Group (1ST), Oneview Healthcare (ONE), Diagnos (ADK), ICSGlobal (ICS), Jayex Healthcare (JHL), CardioComm Solutions (EKG) and Global Health (GLH).
Who are Mach7 Technologies' key executives?
Mach7 Technologies' management team includes the folowing people:
- Mr. Mike Lampron, COO & Interim CEO
- Mr. Ravi Krishnan, Founder & Chief Strategy Officer
- Ms. Jennifer Pilcher, Global CFO & Corp. Sec.
What is Mach7 Technologies' stock price today?
One share of M7T stock can currently be purchased for approximately A$0.77.
How big of a company is Mach7 Technologies?
What is Mach7 Technologies' official website?
How can I contact Mach7 Technologies?
The company can be reached via phone at 802-861-7745.
MarketBeat Community Rating for Mach7 Technologies (ASX M7T)
MarketBeat's community ratings are surveys of what our community members think about Mach7 Technologies and other stocks. Vote "Outperform" if you believe M7T will outperform the S&P 500 over the long term. Vote "Underperform" if you believe M7T will underperform the S&P 500 over the long term. You may vote once every thirty days.
